Effect of Tranexamic Acid on Blood Loss and transfusion in Femoral Fixation Surgeries

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171030037093N18

Enrollment

Registered

2019-09-14

Start date

2019-10-02

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Fixation Surgeries.

Interventions

Intervention 1: Intervention group: The trans-oxamic acid-receiving group was injected intravenously 30 min before surgery with a 15 mg / kg dose of tranexamic acid. Intervention 2: Control group: In

Eligibility

Sex/Gender

All

Age

16 Years to 65 Years

Inclusion criteria

Inclusion criteria: Ages between 16 and 65 years old ASA Class 1 and 2

Exclusion criteria

Exclusion criteria: History of coagulopathy and bleeding disorders Renal impairment History of using antiplatelet and anticoagulant Acute infection A history of malignancy and ASA above 2 and thromboembolic events Hemoglobin levels less than 10 Sensitivity to tranexamic acid

Design outcomes

Primary

Measure	Time frame
Hemoglobin level. Timepoint: On the first day after surgery. Method of measurement: measurement.;Bleeding rate. Timepoint: After surgery at 6, 12, 24 hours after surgery. Method of measurement: measurement.;Blood transfusion rate. Timepoint: During surgery and within 24 hours after surgery. Method of measurement: measurement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHashem Jarineshin

Iran University of Medical Sciences

shmh@hums.ac.ir+98 917 361 3464

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026